Full-Time

Therapy Awareness Manager

Posted on 4/16/2025

Axogen

Axogen

201-500 employees

Develops technologies for peripheral nerve repair

Compensation Overview

$100.5k - $125.7k/yr

+ Bonus

Mid, Senior

Tampa, FL, USA

The job is in-person at the specified address in Tampa, FL.

Category
General Marketing
PR & Communications
Growth & Marketing
Required Skills
Sales
Product Management
Marketing
Requirements
  • Bachelor’s degree required; Master’s Degree (MBA) or equivalent experience is preferred.
  • Minimum 3+ years of proven success in product management, marketing or sales, with a strong focus in pharmaceutical, diagnostics, medical device, or other healthcare industry. Experience developing and launching new technologies in the medical field is a plus.
  • Strong Written and Verbal Communication Skills; Excellent ability to convey complex information to various audiences.
  • Ability to thrive in a fast-paced, collaborative environment, managing multiple priorities with a focus on delivering measurable results.
  • Ability and willingness to travel domestically (up to 50%) to support customer engagements and training.
Responsibilities
  • Develop, plan, and implement educational and marketing activities to raise awareness of advanced treatment options within the healthcare community.
  • Execute high-impact Therapy Awareness events to increase access to Axogen’s portfolio solutions.
  • Build strong relationships with healthcare providers, advocacy groups, and industry leaders to drive market expansion and therapy awareness.
  • Develop regional referral pathways for patients needing specialized evaluation for advanced therapies.
  • Provide clinical expertise and educate healthcare providers on patient selection for Axogen’s solutions.
  • Create patient care pathways to identify high-risk patients who may benefit from Axogen’s therapies.
  • Deliver education to patient support groups and networks to enhance public awareness of treatment options.
  • Assist hospitals in developing marketing materials, CME symposiums, and educational conferences.
  • Institutionalize nerve repair algorithms broadly across specialties at key healthcare accounts to drive consistent treatment approaches.
  • Drive optimization of commercial excellence processes to ensure smooth execution of marketing programs and sales initiatives.
  • Support development of sales tools, training programs, and resources that enhance sales team effectiveness and drive product adoption.
  • Collaborate with sales teams to identify and execute strategies that improve market penetration and expand commercial reach.
  • Partner with cross-functional teams to ensure seamless execution of therapy awareness programs, demand generation efforts, and promotional campaigns.
  • Effectively communicate and collaborate with field team members and sales leadership teams to ensure alignment of marketing efforts.
  • Lead initiatives that establish best practices in account development, ensuring a structured approach to engaging institutions and expanding therapy adoption across multiple disciplines.
  • Support marketing communication programs that enhance technology and technique awareness.
  • Help create impactful sales collateral, digital content, and educational resources to support marketing and sales initiatives.
  • Support planning and execution of major conferences, trade shows, and industry events to maximize brand presence and drive lead generation.
  • Ensure consistent messaging and brand positioning across all marketing channels.
  • Foster strong partnerships with internal teams, including sales, account development, medical affairs, product development, clinical, sales training and market development, to align marketing initiatives with business objectives.
  • Effectively communicate with external stakeholders, including healthcare providers and strategic partners, to drive market expansion.
  • Support strategic planning initiatives by providing data-driven insights and recommendations that influence key business decisions.
  • Work closely with hospital administrators and healthcare systems to embed nerve repair algorithms into clinical practice, ensuring broad adoption across institutions.
Desired Qualifications
  • Therapy awareness and/or market development experience is preferred.
  • Experience regarding New Market Expansion or expanding products and/or therapies into new markets or surgical applications is highly preferred.

Axogen specializes in developing and selling technologies aimed at repairing and regenerating peripheral nerves. Their products are designed to assist surgeons in restoring nerve function for patients who have experienced injuries or surgeries that affect their peripheral nerves. These products help reconnect damaged nerves, which can alleviate issues such as loss of muscle control, sensory feelings, and chronic pain. What sets Axogen apart from its competitors is its dedicated focus on peripheral nerve repair, offering a wide range of clinically proven solutions that are also cost-effective for healthcare providers. The company's goal is to improve the quality of life for patients by enabling them to regain essential functions, such as movement and sensation, that healthy peripheral nerves provide.

Company Size

201-500

Company Stage

IPO

Headquarters

Alachua, Florida

Founded

2002

Simplify Jobs

Simplify's Take

What believers are saying

  • Axogen's new CFO, Lindsey Hartley, brings fresh financial leadership from May 2025.
  • The launch of Avive+ Soft Tissue Matrix enhances Axogen's product portfolio.
  • Rolling submission of Avance Nerve Graft BLA marks regulatory progress.

What critics are saying

  • Increased competition from emerging biotech companies threatens Axogen's market share.
  • Potential FDA approval delays for Avance Nerve Graft could impact timelines.
  • Recent public stock offering may lead to stock dilution and affect investor confidence.

What makes Axogen unique

  • Axogen specializes in surgical solutions for peripheral nerve injuries.
  • Avive+ Soft Tissue Matrix offers temporary protection during nerve healing.
  • Axogen initiated a Biologics License Application for Avance Nerve Graft in May 2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Holidays

Employee Stock Purchase Plan

Tuition Reimbursement

Paid Parental Leave

Paid Caregiver Leave

Basic Life Insurance

Supplemental Life Insurance

Disability Insurance

Company News

RTTNews
May 8th, 2025
Axogen Promotes Lindsey Hartley To Succeed Nir Naor As CFO

Axogen, Inc. (AXGN), a developer of innovative surgical solutions for peripheral nerve injuries, announced the appointment of Lindsey Hartley as Chief Financial Officer, effective May 12, 2025.

Health Promo
Mar 26th, 2025
Axogen Announces Appointment of Rick Ditto as Vice

ALACHUA, Fla. and TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy.

Market Wire News
Jan 10th, 2025
AXGN - Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Craig Swandal as Vice President of Operations.

Investor Brand Network
Nov 7th, 2024
BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Strengthens Clinical Research Team with Appointment of Senior Clinical Scientist

Dr. Peterson, an experienced clinical researcher with a background in both academic and industry roles, joins from Axogen, where he specialized in therapies for peripheral nerve repair.

MedTech Dive
Aug 9th, 2024
Axogen names ex-Abbott exec Michael Dale as CEO

Axogen names ex-abbott exec Michael Dale as CEO.

INACTIVE